Physician profile
Richard Ray
NPI 1982775995
$1,779.93
in general payments reported to CMS, 2019-2025
21 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Neuromusculoskeletal Medicine, Sports Medicine provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $187 · 2021: $423 · 2022: $254 · 2023: $218 · 2024: $159 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $284.29 | 2019-2025 | Zubsolv |
| Collegium Pharmaceutical, INC. | $266.30 | 2019-2025 | Xtampza, Belbuca |
| Biodelivery Sciences International, INC. | $223.27 | 2019-2021 | |
| Indivior INC. | $186.61 | 2019-2025 | Sublocade |
| Braeburn INC. | $116.76 | 2023-2025 | Brixadi |
| Kowa Pharmaceuticals America, INC. | $111.36 | 2022-2023 | Seglentis |
| Hikma Pharmaceuticals USA | $90.89 | 2022-2023 | Ryaltris, Mitigare, Kloxxado |
| Alkermes, INC. | $80.73 | 2019-2022 | |
| Mdd US Operations, LLC | $80.37 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.73 | 2019-2020 | |
| Pacira Therapeutics, INC. | $42.72 | 2019 | |
| Averitas Pharma INC. | $35.62 | 2023-2024 | Qutenza |
| Abbvie INC. | $34.41 | 2022 | |
| Redhill Biopharma INC. | $32.84 | 2021 | |
| Bioventus LLC | $30.88 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $28.23 | 2019 | |
| Horizon Therapeutics Plc | $25.46 | 2020-2022 | |
| Daiichi Sankyo INC. | $16.79 | 2019 | |
| Ani Pharmaceuticals, INC. | $16.48 | 2024 | Purified Cortrophin Gel |
| Shionogi INC | $13.96 | 2019 | |
| Pfizer INC. | $12.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.